Janus kinase-3 dependent inflammatory responses in allergic asthma

Int Immunopharmacol. 2010 Aug;10(8):829-36. doi: 10.1016/j.intimp.2010.04.014. Epub 2010 Apr 27.

Abstract

Allergic asthma is a chronic inflammatory condition of the lung characterized by reversible airway obstruction, high serum immunoglobulin (Ig) E levels, and chronic airway inflammation. A number of cells including mast cells, T cells, macrophages and dendritic cells play a role in the pathogenesis of the disease. Janus kinase (JAK)-3, a non-receptor protein tyrosine kinase, traditionally known to mediate cytokine signaling, also regulates functional responses of these cells. In this review the role of JAK-3 in regulating various pathogenic processes in allergic asthma is discussed. We propose that targeting JAK-3 is a rationale approach to control the inflammatory responses of multiple cell types responsible for the pathogenesis of allergic asthma.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Animals
  • Asthma / drug therapy
  • Asthma / immunology*
  • Asthma / metabolism
  • Dendritic Cells / immunology
  • Drug Design
  • Humans
  • Immunoglobulin E / immunology*
  • Janus Kinase 3 / immunology*
  • Janus Kinase 3 / metabolism
  • Lung / immunology*
  • Lung / pathology
  • Macrophages, Alveolar / immunology
  • Mast Cells / immunology
  • Pneumonia
  • Respiratory Mucosa / immunology
  • Respiratory Mucosa / metabolism
  • Signal Transduction / immunology

Substances

  • Immunoglobulin E
  • Janus Kinase 3